Opportunity Information: Apply for CDC RFA GH21 2105
The grant opportunity titled "Capacity Building for National Immunization Programs in the Eastern Mediterranean Region" (Funding Opportunity Number: CDC RFA GH21-2105) is a CDC cooperative agreement designed to boost the overall strength and day-to-day performance of national immunization programs across countries in the Eastern Mediterranean Region (EMR). The central aim is to help these countries reach major regional vaccine-preventable disease (VPD) targets, especially long-standing global and regional priorities like polio eradication and measles and rubella elimination. In practical terms, the opportunity is focused on reducing illness and deaths caused by vaccine-preventable diseases while also improving readiness for newer or rapidly evolving threats, explicitly including COVID-19.
A major theme of the opportunity is capacity building across the full prevention-to-response cycle for VPDs. That includes strengthening immunization service delivery so routine and campaign vaccination can reach more people reliably, improving comprehensive VPD surveillance so cases and outbreaks are detected earlier and tracked more accurately, and building the operational ability needed to prepare for, detect, and respond to outbreaks. The intent is not only to increase the number of vaccinations delivered, but also to improve the systems that make immunization programs resilient: the tools, workforce, processes, and data systems that allow countries to sustain performance and react quickly when conditions change.
Another core objective is narrowing immunity gaps by focusing on populations that are unvaccinated or undervaccinated and that face higher risk. The recipient is expected to develop and implement targeted strategies to improve access and coverage among these groups, which can include communities affected by conflict or displacement, populations with limited access to health services, remote or mobile groups, or communities facing barriers like mistrust, affordability constraints, or logistical hurdles. The emphasis on targeted strategies suggests a data-driven approach where program efforts are tailored based on where coverage is lowest and where outbreak risk is highest, rather than relying solely on broad, uniform interventions.
The opportunity also highlights sustainability and longer-term institutional strengthening, not just short-term coverage gains. A key component of that is supporting evidence-based decision-making through National Immunization Technical Advisory Groups (NITAGs), which are country-level bodies that guide immunization policies using scientific evidence and local context. In addition, the work includes strengthening immunization safety (for example, systems that monitor and respond to adverse events following immunization and promote safe vaccination practices) and expanding workforce capacity so immunization programs have trained staff and functional management structures. Together, these elements are meant to help countries maintain progress even when external funding or emergency campaign intensity fluctuates.
Program evaluation and learning are also explicitly built into the award’s purpose. The recipient is expected to advance evaluation to increase immunization program impact by identifying persistent program challenges, testing or adapting approaches, and using evidence to guide immunization policy and operational decisions. This signals an expectation that the cooperative agreement will not only implement activities, but also generate usable information about what works in different EMR contexts, then translate that information into improved program performance.
Although the award is rooted in traditional VPD priorities, it is also framed as directly relevant to COVID-19. The work is described as critical for COVID-19 control and as foundational preparation for coronavirus vaccine introduction, reflecting the need for strong delivery systems, surveillance, and outbreak response capacities that can be leveraged for pandemic vaccination and related response activities. The notice also leaves room for supporting other global health priorities aligned with CDC goals, implying some flexibility to address interconnected public health needs as they arise, as long as they fit within the overall immunization and health security objectives.
From an administrative standpoint, the opportunity is offered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), under CFDA 93.318, and uses a cooperative agreement funding instrument. A cooperative agreement typically means CDC expects substantial involvement or partnership in carrying out the work, rather than a fully hands-off grant. The opportunity is listed as discretionary, with eligibility described as unrestricted (open to any type of entity), subject to any additional eligibility clarifications in the full announcement. The posting shows an expected number of awards of one, indicating CDC anticipated selecting a single recipient to carry out the regional or multi-country scope of work. Key dates provided include a creation date of February 19, 2021, and an original closing date of April 20, 2021, with applications due by 11:59 pm Eastern Time on the due date. The award ceiling is shown as 0 in the source data, which usually indicates the ceiling was not specified in that particular listing or was provided elsewhere in the full notice rather than in the summary fields.Apply for CDC RFA GH21 2105
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Capacity Building for National Immunization Programs in the Eastern Mediterranean Region" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
- This funding opportunity was created on Feb 19, 2021.
- Applicants must submit their applications by Apr 20, 2021 Electronically submitted applications must be submitted no later than 1159 pm ET on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: Capacity Building for National Immunization Programs in the Eastern Mediterranean Region (CDC RFA GH21-2105)
What is the name of this grant opportunity?
The opportunity is titled "Capacity Building for National Immunization Programs in the Eastern Mediterranean Region".
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH21-2105.
Who is offering this funding opportunity?
The opportunity is offered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC).
What type of funding instrument is this?
This is a cooperative agreement, which typically means CDC expects substantial involvement and partnership in carrying out the work (as opposed to a fully hands-off grant).
What is the program or CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.318.
Is this a discretionary grant opportunity?
Yes. The listing describes the opportunity as discretionary.
What is the main purpose of this cooperative agreement?
The central purpose is to strengthen the overall capacity and day-to-day performance of national immunization programs across countries in the Eastern Mediterranean Region (EMR), helping countries reach major regional vaccine-preventable disease (VPD) targets.
Which disease priorities are specifically highlighted?
The opportunity specifically highlights long-standing global and regional priorities such as polio eradication and measles and rubella elimination.
How does this opportunity relate to COVID-19?
The work is described as critical for COVID-19 control and as foundational preparation for coronavirus vaccine introduction. The opportunity emphasizes strengthening delivery systems, surveillance, and outbreak response capacities that can also support pandemic vaccination efforts.
What does "capacity building" mean in the context of this opportunity?
In this opportunity, capacity building spans the full prevention-to-response cycle for VPDs. It includes strengthening immunization service delivery, improving comprehensive VPD surveillance, and building operational ability to prepare for, detect, and respond to outbreaks. It also includes strengthening the systems that make immunization programs resilient, such as tools, workforce, processes, and data systems.
What kinds of immunization service delivery improvements are emphasized?
The opportunity emphasizes strengthening immunization service delivery so that routine and campaign vaccination can reach more people reliably and consistently.
What surveillance improvements are included in the intended scope?
The scope includes improving comprehensive VPD surveillance so cases and outbreaks are detected earlier and tracked more accurately.
Does the opportunity focus only on increasing vaccination numbers?
No. While increasing vaccinations is a practical outcome, the intent also emphasizes improving the systems that make immunization programs strong and resilient (workforce, processes, tools, and data systems), so performance can be sustained and adapted when conditions change.
Who should benefit most from the program activities?
A major focus is narrowing immunity gaps by prioritizing unvaccinated and undervaccinated populations that face higher risk and barriers to access.
What types of populations are explicitly mentioned as priorities for targeted strategies?
The description includes communities affected by conflict or displacement, populations with limited access to health services, remote or mobile groups, and communities facing barriers such as mistrust, affordability constraints, or logistical hurdles.
What is meant by "targeted strategies" in this opportunity?
The emphasis on targeted strategies suggests a data-driven approach, tailoring efforts to where coverage is lowest and outbreak risk is highest rather than relying only on broad, uniform interventions.
Is sustainability addressed, or is the focus mainly short-term coverage?
Sustainability is a core theme. The opportunity emphasizes longer-term institutional strengthening, not only short-term coverage gains, with program elements designed to help countries maintain progress even if external funding or emergency campaign intensity changes.
What role do National Immunization Technical Advisory Groups (NITAGs) play in this opportunity?
The opportunity includes supporting evidence-based decision-making through NITAGs, which are country-level bodies that guide immunization policy using scientific evidence and local context.
Does the opportunity include vaccine safety work?
Yes. The scope includes strengthening immunization safety, such as systems that monitor and respond to adverse events following immunization and promote safe vaccination practices.
Is workforce development part of the expected work?
Yes. The opportunity calls for expanding workforce capacity so immunization programs have trained staff and functional management structures.
What is expected regarding program evaluation and learning?
Program evaluation is explicitly built into the purpose of the award. The recipient is expected to advance evaluation to increase immunization program impact by identifying persistent challenges, testing or adapting approaches, and using evidence to guide policy and operational decisions.
Does the opportunity allow flexibility to support other public health priorities?
The notice indicates room for supporting other global health priorities aligned with CDC goals, implying some flexibility as needs arise, as long as activities fit within the overall immunization and health security objectives.
What is the geographic focus of the work?
The work focuses on countries in the Eastern Mediterranean Region (EMR).
How many awards did CDC expect to make?
The posting shows an expected number of awards of one, suggesting CDC anticipated selecting a single recipient to carry out the regional or multi-country scope of work.
Who is eligible to apply?
Eligibility is described as unrestricted (open to any type of entity), subject to any additional eligibility clarifications in the full announcement.
What were the key posted dates for this opportunity?
The posting shows a creation date of February 19, 2021 and an original closing date of April 20, 2021.
When were applications due, and what time zone applied?
Applications were due by 11:59 pm Eastern Time on the due date.
What is the funding ceiling for this opportunity?
The award ceiling is shown as 0 in the source data, which typically indicates the ceiling was not specified in that listing or was provided elsewhere in the full notice rather than in the summary fields.
Browse more opportunities from the same category: Health
Next opportunity: Ambassador’s Special Self-Help (SSH) Program – Africa Regional Democracy Fund (ARDF)
Previous opportunity: Reimagining the Transatlantic Relationship
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH21 2105
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH21 2105) also looked into and applied for these:
| Funding Opportunity |
|---|
| Telehealth Centers of Excellence Apply for HRSA 21 030 Funding Number: HRSA 21 030 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $3,250,000 |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required) Apply for RFA HL 22 008 Funding Number: RFA HL 22 008 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhancing the National Government's Coordination of the National HIV Program to Ensure Sustainability of Quality and Comprehensive HIV Services in Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2118 Funding Number: CDC RFA GH21 2118 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Sickle Cell Disease Newborn Screening Follow-up Program Apply for HRSA 21 036 Funding Number: HRSA 21 036 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $184,000 |
| Sickle Cell Disease Treatment Demonstration Program Apply for HRSA 21 032 Funding Number: HRSA 21 032 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving HIV/TB Policy Implementation in the KwaZulu Natal (KZN) Province in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2133 Funding Number: CDC RFA GH21 2133 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening Public Health Responses and Accelerating HIV/AIDS Program for the Sustainable Provision of Comprehensive HIV/AIDS Services in Oromia Regional State of the Federal Democratic Republic of Ethiopia under PEPFAR Apply for CDC RFA GH21 2109 Funding Number: CDC RFA GH21 2109 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| ACL National Chronic Disease Self-Management Education Resource Center Apply for HHS 2021 ACL AOA CSSG 0020 Funding Number: HHS 2021 ACL AOA CSSG 0020 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $2,000,000 |
| NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) Apply for RFA DE 22 001 Funding Number: RFA DE 22 001 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $650,000 |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 21 019 Funding Number: RFA RM 21 019 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $840,000 |
| Childhood Lead Poisoning Prevention and Surveillance of Blood Lead Levels in Children Apply for CDC RFA EH21 2102 Funding Number: CDC RFA EH21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - NCEH Category: Health Funding Amount: $850,000 |
| Capacity Building for Sustainable HIV Services Apply for HRSA 21 064 Funding Number: HRSA 21 064 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Collecting Violent Death Information Using the National Violent Death Reporting System (NVDRS) Apply for CDC RFA CE21 2105 Funding Number: CDC RFA CE21 2105 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $942,085 |
| Medication Assisted Treatment - Prescription Drug and Opioid Addiction Apply for TI 21 006 Funding Number: TI 21 006 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $1,000,000 |
| Health Information Systems Strengthening for Improved Public Health Care and Program Management in Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2113 Funding Number: CDC RFA GH21 2113 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strategic Prevention Framework for Prescription Drugs Apply for SP 21 001 Funding Number: SP 21 001 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $384,000 |
| Development of a COVID-19 Monitoring System for U.S. Correctional and Detention Facilities Apply for CDC RFA PS21 2107 Funding Number: CDC RFA PS21 2107 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Community Action for HIV Control Activity Apply for 72012121RFA00001 Funding Number: 72012121RFA00001 Agency: Agency for International Development, Ukraine USAID-Kiev Category: Health Funding Amount: $19,500,000 |
| Strengthening HIV/AIDS-related Strategic Information, Laboratory Support, and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2148 Funding Number: CDC RFA GH21 2148 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| ACL National Falls Prevention Resource Center Apply for HHS 2021 ACL AOA FPSG 0019 Funding Number: HHS 2021 ACL AOA FPSG 0019 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH21 2105", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.